Entries by Jill Ettinger

Dr. Andrew Weil Joins Advisory Board for Psychedelic Therapy Platform Field Trip

Acclaimed integrative medicine pioneer, Dr. Andrew Weil, has joined the advisory board for psychedelic therapy platform Field Trip Health. “I am extremely pleased to be joining the medical advisory board at Field Trip,” Dr. Weil said in a statement. “Field Trip’s mission, as well as the energy, enthusiasm and commitment to thoughtful, modern and responsible approaches […]

Field Trip Is the Latest Psychedelic Therapy Company to Go Public

Another psychedelic therapy-based company has gone public. Toronto-based Field Trip Health Ltd., which operates the mobile therapy app Trip, is now trading on the Canadian Securities Exchange under the symbol FTRP. Psychedelic therapy for treatment of mental health issues is becoming big business in the stock market. Most recently, Compass Pathways went public. MindMed applied […]

Oregon’s Democratic Party Endorses Legalization of Psilocybin

Oregon’s Democratic Party is telling voters to vote “yes” on psychedelic substances in November. The party has endorsed state ballot measures calling for the legalization of psilocybin mushrooms for therapeutic purposes and the decriminalization of certain Schedule 1 drugs in the case of recreational possession. Rep. Earl Blumenauer (D-OR) said in an email to Oregon […]

MindMed and NYU Team Up for $5 Million Psychedelic Research and Training Program

Leading psychedelic biotech company, MindMed, has partnered with NYU’s Langone Health center. Together, they’ll work to develop the NYU Langone Health Psychedelic Medicine Research Training Program. It will lead to a psychedelic research center at NYU. The news comes after MindMed’s recent uplisting request submitted to NASDAQ. MindMed works to discover, develop, and distribute psychedelic […]

Dr. Bronner’s Soap Donates $3 Million to Psychedelic Research and Advocacy

Popular natural soap brand Dr. Bronner’s has launched a campaign to promote psychedelic therapy. ‍ Dubbed the “Heal Soul” campaign, Dr. Bronner’s hopes to draw attention to public education and advocacy work helping make psychedelic-assisted therapy mainstream. The family-owned business, started by Dr. Emanuel Bronner in 1948, has already donated more than $3 million in […]

New Oregon TV Ad Supports Psilocybin Legalization Ballot Measure

A new television ad is aimed at convincing Oregonians to vote in favor of legislation that will decriminalize psychedelics. The new ad, which most Oregon residents are likely to see close to seven times before election day, is part of a campaign launched by the Heroic Hearts Project. The program works with veterans seeking psychedelic […]

How Psychedelics Saved Former NBA Star Lamar Odom From Drug Addiction

In a new documentary about his life, former NBA forward Lamar Odom says the psychedelic drugs ketamine and ibogaine saved him from his drug addiction. He says the drugs saved his life. The film, “Lamar Odom Reborn,” was directed by Mike “Zappy” Zapolin, who coordinated the psychedelic “intervention” for Odom. Zapolin, whose resume includes a […]

Ibogaine and LSD Producer MindMed Applies for Nasdaq Up-Listing

Just days after UK-based psychedelic developer Compass Pathways went public, New York-based MindMed has applied for a Nasdaq up-listing. The company, valued at $190 million,  is already listed on Canada’s NEO exchange. MindMed is currently trialing two psychedelic drugs including LSD and a derivative of ibogaine for treatment of anxiety disorders and opioid addiction. Ibogaine is a […]

Taking a Psychedelic Trip? There’s an App for That

There are apps for nearly everything, these days. Now, there’s even an app to guide you through a psychedelic experience. Field Trip Psychedelics Inc., which operates clinics in Toronto, New York, and Los Angeles, has launched Trip, an app designed to support the “self-exploration and consciousness expansion” during a psychedelic experience. “As we began building out […]